In silico study of six FDA approved anti-HCV drugs as inhibitors for NS5 methyltransferase of dengue virus type 2
- Citation:
- Khater, I. M., and A. M. Nassar,
In silico study of six FDA approved anti-HCV drugs as inhibitors for NS5 methyltransferase of dengue virus type 2,
: Medknow Publications, 2022.
Abstract:
n/a
Notes:
n/a
